Godrej Consumer Products FY25 Annual Earnings Summary
3 quarters covered · ₹10,766 Cr revenue · ₹1,440 Cr PAT · 6.7% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY25Risks flagged during the year
Extreme currency fluctuations in Nigeria and Ghana led to distributor destocking and a 21% volume decline in GAUM. High interest rates may prolong the destocking.
Q2 FY25 · highSharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.
Q3 FY25 · highManagement noted a significant urban slowdown, with premium products and modern trade under pressure, which could persist and impact growth.
Q1 FY25 · mediumSharp increase in palm oil prices pressured India EBITDA margins in Q1, and management noted it as a headwind for the year.
Q1 FY25 · mediumIntegration of urban general trade distribution led to market share loss in deodorants. Management is reverting to a specialized channel, which may delay profit targets.
Q2 FY25 · mediumUrban general trade is under pressure from quick commerce disruption and consumption slowdown, which could impact distribution and sales.
Q2 FY25 · mediumRaymond consumer portfolio may miss the 145-150 crore EBITDA target due to distribution issues in urban GT, though management expects only a slight shortfall.
Q2 FY25 · mediumMarket leader's adoption of bathing bar technology could widen price gap, though management believes quality focus will protect market share.
Q3 FY25 · mediumDespite palm oil correction, PFAD prices remain high, delaying margin normalization in soaps. Management expects margins to remain similar in Q4.
Q3 FY25 · mediumOnly 40-50% of offtakes in liquid vaporizers are RNF, with old product still in pipeline. Full transition may take longer.
Q1 FY25 · lowThe INR 500 crore investment in pet care is a long-term bet with uncertain returns. Management acknowledged EBITDA margins may be lower than HPC.
Q3 FY25 · lowCompetitors like Rin have lowered prices in liquid detergents, potentially challenging Fab's growth trajectory.
What changed through the year
Q1 FY25 · India pricing to turn positive from Q2 FY25
Management expects pricing to become positive sequentially from Q2, with full-year pricing growth of 2-3%.
Q1 FY25 · India volume growth target of low double-digit for FY25
Management aims for low double-digit volume growth in India for the full year, implying acceleration from 8% in Q1.
Q1 FY25 · Raymond business EBITDA to be 15-20% below target of INR 160 crore
Raymond acquisition EBITDA for FY25 is expected to be 15-20% below the original target of INR 160 crore, but significantly higher than the inherited INR 60 crore.
Q1 FY25 · Pet care subsidiary to be cash positive in five years
Godrej Pet Care is expected to become cash positive after five years, with manufacturing commencing in H2 FY26.
Q2 FY25 · India EBITDA margin to remain in 24-25% range for next two quarters
Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investments.
Q2 FY25 · RCCL EBITDA may fall short of 145-150 crore target
The Raymond consumer portfolio EBITDA may be slightly below the promised 145-150 crore for the year due to distribution missteps in urban general trade.
Q2 FY25 · HI category to aim for high single-digit volume growth
Management targets high single-digit volume growth for household insecticides, driven by RNF molecule rollout and distribution expansion.
Q2 FY25 · Africa margins to improve to high teens over next year or two
Africa EBITDA margins are expected to reach high teens, driven by supply chain efficiencies and stable macro conditions.
Q3 FY25 · India volume and value growth sequential improvement in Q4 FY25
Management expects volume and value growth to improve sequentially in Q4 FY25, with a return to H1-like levels by Q1 FY26.
Q3 FY25 · India EBITDA margin target of 24-26%
Management targets India EBITDA margins in the 24-26% range, expecting to reach this level in the next 6-8 months.
Q3 FY25 · Africa organic revenue growth positive by Q4 FY25
Management expects Africa business to report positive organic revenue growth by Q4 FY25.
Q3 FY25 · Further pricing actions in soaps
Management indicated need for one or two more rounds of pricing in soaps to restore normative margins.